Funding for this research was provided by:
P.L. is supported by Schmidt Science Fellows.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI132122)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS103172)
U.S. Department of Health & Human Services | NIH | National Eye Institute (EY029166)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (HG004659, HG009889)
This research was partially supported by an Allen Distinguished Investigator Award to G.W.Y., a Paul G. Allen Frontiers Group advised grant of the Paul G. Allen Family Foundation.
Received: 28 November 2021
Accepted: 6 May 2022
First Online: 13 June 2022
: G.W.Y. is a SAB member of Jumpcode Genomics and a co-founder, member of the Board of Directors, scientific advisor, equity holder and paid consultant for Locanabio and Eclipse BioInnovations. G.W.Y. is a visiting professor at the National University of Singapore. G.W.Y.’s interests have been reviewed and approved by the University of California San Diego, in accordance with its conflict-of-interest policies. The authors declare no other competing interests.
Free to read: This content has been made available to all.